Apply on Employer Site

CSL · 21 hours ago

Senior Director, Early Partnerships & Transactions Lead

King of Prussia, PA

Full-time

Hybrid

Director/Executive

15+ years exp

CSL is a global biotherapeutics leader focused on developing innovative therapies for patients. The Senior Director, Early Partnerships & Transactions Lead will drive early-stage deal-making and develop partnership strategies to enhance external innovation and create competitive advantages for the organization.

BiotechnologyHealth CareHealth DiagnosticsMedical

Comp. & Benefits

Responsibilities

Lead Early-Stage Deal-Making: Drive MTAs, research collaborations, options-to-license, and other innovative structures to accelerate external innovation

Source Strategic Assets: Partner with big pharma BD teams to identify and onboard deprioritized assets; maintain strong relationships with academia, biotech, and investors

Develop Partnership Strategy: Create onboarding advantages and transaction pathways that position the organization as a preferred partner

Align and Influence: Communicate deal vision and strategic rationale internally; collaborate with BD to amplify priorities to banks, VCs, and the investment community

Innovate Models: Design new partnership and funding approaches to expand deal-making capabilities

Ensure Governance & Performance for Early Partnerships: Set success metrics, monitor progress, and deliver value through disciplined execution

Qualification

Business developmentDeal structuringAlliance managementNegotiation skillsStrategic thinkingNetworking in pharmaAdvanced degreeRelationship buildingLeadership experience

Required

15+ years in biopharma business development, alliance management, or external innovation roles, with 10+ years in senior leadership positions

Demonstrated success in structuring and closing complex deals, including early-stage collaborations and creative funding models

Strong network within pharma BD organizations, biotech, and investment communities

Exceptional negotiation, relationship-building, and strategic thinking skills

Preferred

Advanced degree preferred (MBA, PhD, or equivalent)

Company

CSL

Glassdoor4.6

CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.

Founded in 1916

Melbourne, Victoria, AUS

10001+ employees

https://www.csl.com

Funding

Current Stage

Public Company

Total Funding

$111M

2013-12-20Acquired

2004-02-06Post Ipo Equity· $111M

1994-06-03IPO

Leadership Team

Jeffrey Ball

Chief Sustainability Officer

Joy Linton

Strategic Advisor

Recent News

Pharma Letter

MHRA approves Kostaive mRNA COVID-19 vaccine

2026-01-03

MarketScreener

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

2025-12-07

thefly.com

CSL just upgraded at Canaccord, here's why

2025-10-29

Company data provided by crunchbase